# Citeline

> Citeline is a Norstella company selling clinical-trial, drug-pipeline and investigator intelligence, alongside recruitment technology, regulatory disclosure software and expert services. Pharmaceutical companies, biotechnology firms and contract research organizations use its connected datasets to plan studies, select sites and assess competition.

- **Founded:** 1997
- **Headquarters:** New York, United States
- **Founders:** Zorba Lieberman (Co-founder; identified as an original proprietor in Informa’s company history), Pete Sikora (Co-founder; former president)
- **Products:** Trialtrove / Trialtrove+, Sitetrove / Sitetrove+, Pharmaprojects / Pharmaprojects+, Citeline SmartSolutions, TrialScope Disclose
- **Notable:** Trialtrove was adopted by nearly all top-20 pharmaceutical companies in 2004-2005, according to Informa’s historical investor presentation., Joined Norstella through the merger completed November 1, 2022., Citeline currently reports portfolio coverage of 400,000+ trials, 96,000+ drugs and 535,000+ investigators; these are company-reported coverage metrics.

## Products & services

- **Trialtrove / Trialtrove+** — Curated trial intelligence covering design, endpoints, enrollment and timelines; the Plus edition adds performance analytics and Ella search assistance.
- **Sitetrove / Sitetrove+** — Investigator and research-site intelligence; enhanced tools compare experience, capacity, enrollment performance and expert networks.
- **Pharmaprojects / Pharmaprojects+** — Global drug-development tracking from discovery to launch; enhanced tools include Company Compare and Drug Similarity.
- **Citeline SmartSolutions** — AI-enabled planning tools including Protocol SmartDesign, Investigator SmartSelect and Cohort SmartBuilder.
- **TrialScope Disclose** — Clinical-trial registration, results disclosure, workflows and registry submissions; includes an AI Importer and Global Disclosure Form.
- **Citeline Connect** — Patient education, engagement and recruitment technology connecting sponsors, recruitment partners and research sites.
- **Patient Intelligence** — Connects epidemiology, standard-of-care information, patient journeys and patient access/proximity with trial, site and pipeline intelligence.
- **Expert and custom services** — Ask-The-Analyst support, consulting, analytics, feasibility services and regulatory/medical writing.
- **Life-sciences publications** — Specialist reporting including Pink Sheet, Scrip, In Vivo and Medtech Insight.

## Achievements

- Trialtrove was adopted by nearly all top-20 pharmaceutical companies in 2004-2005, according to Informa’s historical investor presentation.
- Joined Norstella through the merger completed November 1, 2022.
- Citeline currently reports portfolio coverage of 400,000+ trials, 96,000+ drugs and 535,000+ investigators; these are company-reported coverage metrics.

## Latest updates

- **2026-02** — Announced Evinova data integration partnership on February 26.
- **2026-03** — Expanded the Recursion partnership on March 31.
- **2026-07** — Announced Cytel partnership and Enforesys 4.0 data integration on July 31.
- **2026-09** — Launched Patient Intelligence on September 10.

## Links

- Website: https://www.citeline.com/
- LinkedIn: https://www.linkedin.com/company/citeline/
- Twitter/X: https://twitter.com/Citeline
- YouTube: https://www.youtube.com/@CitelineYouTube
- Facebook: https://www.facebook.com/Citeline

---

Profile page: https://yespress.io/citeline
Published by YesPress — https://yespress.io
Last updated: 2026-10-17